Last reviewed · How we verify

NCT06341881

Understanding the Need and Feasibility of Transitional Care Training Program Among Family Caregivers of Geriatric Stroke Survivors in Pakistan

Completed NA Last updated 24 June 2025
What this trial tests

NA trial testing Transitional Care Training Program in Stroke in 60 participants. Completed in 25 March 2025.

Timeline
15 July 2024
Primary endpoint
10 February 2025
25 March 2025

Quick facts

Lead sponsorKhyber Medical University Peshawar
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment60
Start date15 July 2024
Primary completion10 February 2025
Estimated completion25 March 2025
Sites3 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Khyber Medical University Peshawar

Who can join

Adults 18 to 60, any sex, with Stroke or Stroke, Ischemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main intention of the study is to understand the need and feasibility of transitional care training program among family caregivers of geriatric stroke survivors in Pakistan

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Understanding the need and feasibility of a transitional care training program for family caregivers of geriatric stroke survivors.
    Ali S, Naz N, Muhammad D, Khanum S, et al · · 2026 · PMID 41872826 · DOI 10.1186/s12912-026-04541-y

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Khyber Medical University Peshawar trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06341881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing